Menu
IDRA-21 is a drug derived from the benzothiadiazine (not to be confused with benzodiazepine) chemical structure.
As it is a nootropic substance, IDRA-21 has been shown in a clinical setting to improve cognitive ability with little to no adverse effects. However, it is also important to point out that IDRA-21 is still a very new substance to the world, and still currently has more anecdotal evidence for efficacy compared to the amount of available lab research.
In a study done with patas monkeys, the experimenters measured the subjects’ cognitive performance in a complex behavioral task. The monkeys were given the drug alprazolam before the task was given in order to induce a learning deficit (Thomas et al.) The known nootropic drug aniracetam was pitted against IDRA-21 to test the latter’s efficacy in reversing impairment.
Results showed that the IDRA-21 was ten times as powerful as the aniracetam in terms of dosage, meaning that the effects were far more potent dose per dose. The effects of IDRA-21 remained persistent for three days after a single dose, marking it as an extremely long-lasting nootropic especially when compared to the roughly 2 to 3 hour windows given by many other ampakines.
PRECAUTION AND DISCLAIMER:
This Material is Sold For Research Use Only. Terms of Sale Apply. Not for Human Consumption, nor Medical, Veterinary, or Household Uses.
| Size | 1g, 2g, 5g, 10g |
|---|
| Application | Positive allosteric modulator of the AMPA receptor and a benzothiadiazine derivative |
| CAS | 22503-72-6 |
| Molar Mass | 232.69 g/mol |
| Chemical Formula | C8H9ClN2O2S |
| IUPAC Name | 7-chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide |
| Synonyms | 22503-72-6, Idra-21,7-Chloro-3-methyl-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine 1,1-dioxide, 7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide,7-Chloro-3,4-dihydro-3-methyl-2H-1,2,4-benzothiadiazine 1,1-dioxide,163936-78-5, (+)-IDRA-21, (-)-IDRA-21, AC1L1GHQ, AC1Q3ORY, Biomol-NT_000225, CHEMBL77862, SCHEMBL195328, BPBio1_001088GTPL4219, CTK4E9603, AOB5944, DTXSID70936887, EX-A737, CHEBI:111162, HMS3267D13, HMS3412O19, HMS3676O19, BCP19065, KS-00000GF1, 7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine-S,S dioxide, MFCD00270874, AKOS024456473, API0008958, FCH1331231, 2H-1,2,4-Benzothiadiazine, 7-chloro-3,4-dihydro-3-methyl-, 1,1-dioxide, (+)-, 2H-1,2,4-Benzothiadiazine, 7-chloro-3,4-dihydro-3-methyl-, 1,1-dioxide, (-)-, 7-chloro-3-methyl-3,4-dihydro-2H-1, NCGC00025050-02, 163936-79-6, AK326156, DS-11824, SC-90074, CS-0021632, FT-0700269, ST50825828, SR-01000597374, J-014742, SR-01000597374-1, BRD-A14344385-001-01-6, BRD-A14344385-001-02-4, 7-chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine, 7-chloro-3-methyl-3H-benzo[e]1,2,4-thiadiazaperhydroine-1,1-dione, 2H-1,2,4-Benzothiadiazine, 7-chloro-3,4-dihydro-3-methyl-, 1,1-dioxide, 2H-1,2,4-Benzothiadiazine,7-chloro-3,4-dihydro-3-methyl-, 1,1-dioxide, 7-chloro-3-methyl-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-1,1-dione, 7-Chloro-3-methyl-3,4-dihydro-2H-1,2,4-benzothiadiazine S,S-dioxide, 2H-1,2,4-Benzothiadiazine,7-chloro-3,4-dihydro-3-methyl-, 1,1-dioxide; 7-Chloro-3-methyl-3,4-dihydro-1lambda~6~,2,4-benzothiadiazine-1,1(2H)-dione |
| Storage | Store at room temperature, tightly sealed, away from heat, light and moisture. |
| Solubility | Soluble in DMSO |
| Organoleptic Profile | White to off-white powder |
| Physical Form | Solid |
| Specification | ≥98% |
| Terms | This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms & Conditions prior to ordering. |
